Orum Therapeutics

Director

• Lead the I&I TA; working closely with strategic thought partners, build the capability of I&I at Orum, and develop the resourcing strategy
• In collaboration with Orum leadership, lead development of I&I corporate-level strategy and provide guidance as appropriate
• Lead and mentor I&I Project/Program Lead(s) as the TA grows
• Lead internal and external experts (Biology, Chemistry, DMPK, Toxicology, etc.) to achieve project/program goals as one cross-functional team
• Drive formation of the project/program’s integrated development strategy, develop alternative strategies
• Identify risks and develop mitigation plans
• Oversee execution of the integrated development strategic plan
• Ensure that the right assays, animal models and human-based ex vivo platforms are used to de-risk the projects/programs
• Manage and monitor CRO activities to drive project momentum
• Design robust target validation and biomarker strategies throughout the project lifecycle to drive successful transitions from pre-clinical proof-of-concept to human clinical trials
• Identify resource gaps to meet aggressive timelines
• Hold matrixed team members accountable to their responsibilities
• Drive the application of immunological methods to understand disease mechanisms and therapeutic interventions
• Serve as a key thought leader in immunology; generate new therapeutic hypotheses and guide the scientific direction of project/program efforts
• Make data-driven decisions and pivot strategies with agility
• Stay at the forefront of emerging science and modalities in the I&I field
• Keep abreast of and understand competitive advancements that may influence strategic planning for Orum assets
• Serve as the primary point of contact for external partners, scientific advisory boards, etc.
• Represent Orum’s I&I projects/programs at major scientific conferences, with prospective partners, and in due diligence discussions
• Foster a culture of transparency and accountability
• Use a culture of feedback to strategically align the team
• Proactively act as a mentor to junior project/program leads and scientists, empowering them to direct their own paths in alignment with Orum’s core values

Senior/Executive Director, Immunology & Inflammation

Conversion Rate Optimizer

• Oversee the external development of our Degrader-Antibody Conjugate (DAC) pipeline
• Manage high-stakes projects at CROs, specifically overseeing the synthesis of proprietary molecular glue degrader payloads and their conjugation to therapeutic antibodies
• Proactively identify and vet CROs that offer specialized expertise in relevant in-vitro activity assays, in vivo studies, linker-payload synthesis, and complex bioconjugation
• Support the expansion of our TPD²® (Degradation) and TPS²™ (Stabilization) platforms by identifying specialized Chinese partners capable of advanced physics-based modeling and machine learning-driven payload design
• Drive IND-enabling studies for candidates like ORM-1153 (CD123-targeting DAC) and support ongoing clinical-stage programs
• Navigate the "China price" ecosystem to find cost-effective, high-quality alternatives for R&D without compromising the integrity of our AnDC™ (Antibody neoDegrader Conjugate) technology

External Research Leader – CRO

Manager

• 공시 사업보고서, 분·반기보고서, 주요사항보고 등 정기·수시 공시 작성 및 제출
• 다양한 공시 사이클(정기/비정기/이슈성) 운영 및 관리
• KOSDAQ 공시 규정 준수 및 KRX·FSS 대응
• 공시 일정 및 프로세스 관리
• 전환사채, 증자 등 자본시장 관련 공시 업무 지원
• 외부 감사인 및 법무 자문과 협업하여 정기 보고서 기재 내용 관리
• IR 및 대외 커뮤니케이션(필요 시)
• IR 자료 및 공시 연계 자료 작성·업데이트
• 실적 발표, 투자자 미팅 등 IR 활동 지원
• 공시 내용과 대외 메시지 간 일관성 확보
• 주식기반보상(Equity Compensation) 주식기반보상 관련 공시 및 내부 절차 운영
• 주식기반보상 행사·베스팅 등과 관련된 행정 및 유관 부서 협업
• 주식기반보상 관련 이사회·주주총회 안건 지원

Senior/Executive Director, Immunology & Inflammation

External Research Leader – CRO

Disclosure Manager, IR